Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Head and Neck Cancer

  Free Subscription


05.10.2026

1 Am J Gastroenterol
1 Ann Surg
6 Anticancer Res
4 BMC Cancer
1 Br J Cancer
2 Br J Oral Maxillofac Surg
2 Clin Cancer Res
1 Dis Esophagus
2 Head Neck
2 Int J Radiat Oncol Biol Phys
2 J Laryngol Otol
2 J Oral Maxillofac Surg
4 Oral Oncol
1 Radiology
1 Thyroid


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Gastroenterol

  1. SAWAS T, Davitkov P, Zhou M, Eluri S, et al
    Adjunctive Use of p53 Immunohistochemistry for Risk Stratification in Barrett's Esophagus: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2026;121:2411-2422.
    PubMed         Abstract available


    Ann Surg

  2. KRAUSS DT, van der Sluis PSL, Schiffmann LM, Schlosser HA, et al
    The Impact of Robotics on Benchmarking Criteria for the Surgical Treatment of Esophageal Cancer in Western Centers- An Evaluation Using the IDEAL Framework.
    Ann Surg. 2026 Oct 1. doi: 10.1097/SLA.0000000000007230.
    PubMed         Abstract available


    Anticancer Res

  3. KAMM W, Zhang QI, Mortensen L, Wuertz B, et al
    Triptolide as a Chemosensitizer in Human Papillomavirus Head and Neck Squamous Cell Carcinoma Through TP53.
    Anticancer Res. 2026;46:5359-5373.
    PubMed         Abstract available

  4. LEE ST, Chen PN, Chen KM, Wu YC, et al
    Acacetin Promotes Cell Death and Inhibits Migration in Follicular Thyroid Cells.
    Anticancer Res. 2026;46:5453-5465.
    PubMed         Abstract available

  5. WANG R, Zhang QI, Fan R, Gao Y, et al
    Alpha-catenin Mutation-associated Synchronous Follicular Thyroid Carcinoma and Papillary Thyroid Carcinoma With Numerous Adenomatoid Nodules.
    Anticancer Res. 2026;46:5775-5779.
    PubMed         Abstract available

  6. KIM NR, Cho SJ
    Molecular Profiling of Archival Tonsillar Squamous Cell Carcinoma in a Korean Pre-HPV-vaccination Cohort.
    Anticancer Res. 2026;46:5679-5687.
    PubMed         Abstract available

  7. WANG X, Miao Q, Liu X, Liu F, et al
    FXR1 Promotes Esophageal Squamous Cell Carcinoma via JAK2/STAT3/B7-H3 Pathway.
    Anticancer Res. 2026;46:5467-5481.
    PubMed         Abstract available

  8. TAMURA H, Otsuki Y, Hosokawa A
    Pembrolizumab plus Chemotherapy for Synchronous Multiple Primary Esophageal and Gingival Squamous Cell Carcinomas.
    Anticancer Res. 2026;46:5759-5766.
    PubMed         Abstract available


    BMC Cancer

  9. ALNOUR A
    Pleomorphic adenoma: does the immunohistochemical profile direct the clinical profile: retrospective study and review of literature.
    BMC Cancer. 2026;26:1152.
    PubMed         Abstract available

  10. ALI A, Bari MF, Arshad S, Wahid M, et al
    Spatial profiling of tissue-resident memory T cells reveals stromal IL-15 niches and a paradoxical CD103(+) phenotype predicting survival in oral squamous cell carcinoma.
    BMC Cancer. 2026;26:1169.
    PubMed         Abstract available

  11. WANG W, Zhang X, Sun X, Wang L, et al
    Comparative efficacy and safety of first-line immunotherapy- and targeted therapy-based regimens for advanced gastric and gastroesophageal junction cancer: a network meta-analysis.
    BMC Cancer. 2026;26:1146.
    PubMed         Abstract available

  12. GRUETER K, Sander N, Coen L, Husken S, et al
    Co-expression of non-signaling CARs enhances EGFRvIII-specific CAR T-cell cytotoxicity against head and neck squamous cell carcinoma.
    BMC Cancer. 2026;26:1149.
    PubMed         Abstract available


    Br J Cancer

  13. TENGLER L, Jackson EK, Bieback K, Roth R, et al
    Small extracellular vesicles from the plasma of head and neck cancer patients induce dysfunctional T cell phenotypes.
    Br J Cancer. 2026 Sep 26. doi: 10.1038/s41416-026-03606.
    PubMed         Abstract available


    Br J Oral Maxillofac Surg

  14. KUMAR S, Gupta N, Kumar Singh S, Srinivasan H, et al
    Comment on "Exploring prevalence of Head and Neck Cancer and Skin Cancer Kent and Medway to identify health inequity".
    Br J Oral Maxillofac Surg. 2026 Sep 16:S0266-4356(26)00239.
    PubMed        

  15. BAGCHI PR, Yennemadi SR
    Letter to the Editor regarding "Textbook Outcome follow up: bridging short-term success and long-term outcomes in head and neck cancer".
    Br J Oral Maxillofac Surg. 2026 Aug 30:S0266-4356(26)00224.
    PubMed        


    Clin Cancer Res

  16. MALASSIGNE V, Puech J, Imbeaud S, Auperin A, et al
    HPV16 Genomic Status Stratifies Risk of Disease Recurrence in Oropharyngeal Squamous Cell Carcinoma.
    Clin Cancer Res. 2026;32:4434-4447.
    PubMed         Abstract available

  17. WYRWICZ L, Dechaphunkul A, Lee JS, Turpin A, et al
    A Randomized, Nivolumab-Controlled, Phase II Biomarker Study of Lomvastomig and Tobemstomig in Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus.
    Clin Cancer Res. 2026;32:4319-4330.
    PubMed         Abstract available


    Dis Esophagus

  18. OKUI J, Lyu HG, Prakash LR, Li JJ, et al
    Automated detection of gastroesophageal adenocarcinoma recurrence from electronic health records.
    Dis Esophagus. 2026;39:doag109.
    PubMed         Abstract available


    Head Neck

  19. XU R, Huang MJ, Jiang ZH, Liu L, et al
    Neoadjuvant Anlotinib Plus Paclitaxel-Cisplatin for Technically Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma: A Prospective Single-Arm Phase II Study.
    Head Neck. 2026 Sep 30. doi: 10.1002/hed.70501.
    PubMed         Abstract available

  20. SAVOIA G, Hier MP, Sadeghi N, Mlynarek A, et al
    Pretreatment Cachexia Index Is Associated With Severe Treatment Toxicity and Overall Survival in HPV-Negative Head and Neck Squamous Cell Carcinoma.
    Head Neck. 2026 Oct 1. doi: 10.1002/hed.70500.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  21. HORN A, Sherman E, Lee N, Yu Y, et al
    A Phase 2 Study of Postoperative Xevinapant and Chemoradiation for Patients With High-Risk Resected Head and Neck Squamous Cell Carcinomas.
    Int J Radiat Oncol Biol Phys. 2026 Sep 17:S0360-3016(26)04231.
    PubMed        

  22. WANG Q, Jin D, Wang Y, Wu L, et al
    WITHDRAWN: Metastatic Lymph Node Station Classification in Esophageal Cancer via Prior-Guided Supervision and Station-Aware Mixture-of-Experts.
    Int J Radiat Oncol Biol Phys. 2025;123.
    PubMed        


    J Laryngol Otol

  23. CHIARI F, Carosi C, Fermi M, Presutti L, et al
    Surgical management of parapharyngeal vagal schwannomas: a systematic review and practical considerations for approach selection.
    J Laryngol Otol. 2026;140:954-962.
    PubMed         Abstract available

  24. SATTAR Z, Mowat A, Barraclough J
    Septal melanoma: does surgical excision confer a potential survival benefit? A single centre's experience and literature review.
    J Laryngol Otol. 2026 Jun 23:1-20. doi: 10.1017/S0022215126105283.
    PubMed        


    J Oral Maxillofac Surg

  25. NOY R, Graieb M, Shkedy Y, Taha A, et al
    Outcomes of Free-Flap Reconstructive Microsurgery in Frail Head and Neck Patients.
    J Oral Maxillofac Surg. 2026;84:1690-1697.
    PubMed         Abstract available

  26. WARD BB, Kademani D, Qaisi M, Shupak RP, et al
    American Association of Oral and Maxillofacial Surgeons' Position Paper on the Management of the Clinically Negative Neck (cN0) in cT1N0 and cT2N0 Oral Squamous Cell Carcinoma.
    J Oral Maxillofac Surg. 2026;84:1675-1689.
    PubMed         Abstract available


    Oral Oncol

  27. YANAN D, Zhao T, Chuanliang S, Junzheng W, et al
    Comments on: prognostic value of the 5-Item Modified Frailty Index in elderly patients undergoing free flap reconstruction for head and neck cancer.
    Oral Oncol. 2026;182:108154.
    PubMed        

  28. LONG CQ
    Interpreting distant metastasis risk in MRI-Defined N3 nasopharyngeal carcinoma in the presence of competing events.
    Oral Oncol. 2026;182:108160.
    PubMed        

  29. SMITH JD, Santiago R, Doerfler R, Harris MK, et al
    The impact of regional lymph node depletion on response to anti-PD-1 therapy in recurrent and metastatic head and neck squamous cell carcinoma.
    Oral Oncol. 2026;182:108155.
    PubMed         Abstract available

  30. URAGUCHI K, Rikitake R, Tsumura M, Ando M, et al
    Board-certified facilities and survival in head and neck cancer in Japan: A hospital-based cancer registry study.
    Oral Oncol. 2026;182:108152.
    PubMed         Abstract available


    Radiology

  31. RAI P, Bhatt AA
    Rethinking the Role of CT- and MRI-detected Extranodal Extension in Nasopharyngeal Carcinoma: An Early Career Perspective.
    Radiology. 2026;320:e262601.
    PubMed        


    Thyroid

  32. ALZAHRANI AS, Benito A, Alghamdi B, Alqahtani A, et al
    Exceptional and Durable Response to Selpercatinib in a Patient with Apparently RET-Negative, HRAS-, and NF1-Mutated Metastatic Medullary Thyroid Carcinoma.
    Thyroid. 2026 Oct 1:10507256261493665. doi: 10.1177/10507256261493665.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum